Skip to main content
. 2015 Mar 30;10(3):e0121912. doi: 10.1371/journal.pone.0121912

Fig 1. Comparison of bone marrow blast immunophenotypic surface marker expression percentage between newly diagnosed and relapsed patients.

Fig 1

The percentage expression of common APL surface markers like CD13, CD33, CD34, CD38, VLA4 and VLA5 are illustrated as grouped bar graphs for newly diagnosed (black bars) and at relapse (grey bars). The mean±SEM were significantly different for CD13, CD34 and CD38 between the newly diagnosed and relapsed patients.